Huntington National Bank’s Anixa Biosciences ANIX Stock Holding History

Huntington National Bank’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-40	Closed	–	–	1541
2018 Q4	$0	Buy	+40	New	+$172	﹤0.01%	1637

Other funds holding ANIX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Huntington National Bank's ANIX Position: Q1 2019 in Review

Huntington National Bank sold out of Anixa Biosciences (ANIX) in Q1 2019, closing a stake of 40 shares.

Huntington National Bank first reported a position in ANIX in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 17 funds tracked by Wall St. Rank hold ANIX as of Q1 2019.

Huntington National Bank reported no remaining Anixa Biosciences position as of Q1 2019 after selling out during the quarter.
Huntington National Bank sold 40 Anixa Biosciences shares in Q1 2019.
Huntington National Bank first reported a position in Anixa Biosciences in Q4 2018 and held it in 1 quarter.
Huntington National Bank's Anixa Biosciences position peaked at $0 in Q4 2018.
17 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2019.

Based on Huntington National Bank's 13F filing for Q1 2019, filed 9 Apr 2019.